Wu Jian, Zhao Jiangman, Cheng Yinhong, Zhou Haoliang, Shen Guanqiao, Ding Hongying, Lv Jin, Dong Shiye, Tang Oushan
Department of Cardiovascular Medicine, Shaoxing Second hospital, Shaoxing, Zhejiang, China.
Shanghai Biotecan Pharmaceuticals Co., Ltd, Shanghai, China.
J Transl Med. 2025 Mar 14;23(1):329. doi: 10.1186/s12967-025-06295-8.
In order to explore the differences in gut microbiota and their metabolites between patients with H-type hypertension and non-H-type hypertension.
Our study included 100 hypertensive patients from the Department of Cardiology at Shaoxing Second Hospital, with 51 patients having H-type hypertension (H group) and 49 having non-H-type hypertension (non-H group). Blood samples were collected for clinical and metabolite testing, and fecal samples were collected for 16 S rRNA sequencing and metabolite testing.
No significant difference in the α and β diversity of the gut microbiota between the two groups of patients were observed. However, at the phylum level, patients in the non-H group have a higher abundance of Firmicutes and a lower abundance of Actinobacteriota. At the genus level, compared to the non-H group, the H-type group has a higher abundance of Bifidobacterium; at the species level, the Non-H group has a higher abundance of Bacteroides vulgatus and lower abundances of Bacteroides stercoris and Bacteroides plebeius. In the serum of both groups, the concentrations of Acetate and Isobutyrate were significantly higher in the H group (P < 0.05), while in the feces of both groups of patients, the concentration of Malonate was significantly higher in the Non-H group.
The microbial sequencing shows distinct differences between the H and non-H groups, with the latter having higher Firmicutes and Bacteroides vulgatus, while the H group has more Bifidobacterium and higher serum acetate levels. These variations suggest unique gut microbiota compositions and metabolite profiles for each group.
探讨H型高血压患者与非H型高血压患者肠道微生物群及其代谢产物的差异。
本研究纳入绍兴第二医院心内科100例高血压患者,其中H型高血压患者51例(H组),非H型高血压患者49例(非H组)。采集血样进行临床和代谢产物检测,采集粪便样本进行16S rRNA测序和代谢产物检测。
两组患者肠道微生物群的α多样性和β多样性无显著差异。然而,在门水平上,非H组患者的厚壁菌门丰度较高,放线菌门丰度较低。在属水平上,与非H组相比,H型组双歧杆菌丰度较高;在种水平上,非H组普通拟杆菌丰度较高,而粪拟杆菌和多形拟杆菌丰度较低。在两组患者的血清中,H组的乙酸盐和异丁酸盐浓度显著较高(P<0.05),而在两组患者的粪便中,非H组的丙二酸盐浓度显著较高。
微生物测序显示H组和非H组之间存在明显差异,后者厚壁菌门和普通拟杆菌含量较高,而H组双歧杆菌较多,血清乙酸盐水平较高。这些差异表明每组都有独特的肠道微生物群组成和代谢产物谱。